Trial Profile
A Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Aug 2018
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary)
- Indications Community-acquired pneumonia; Skin and soft tissue infections; Urinary tract infections
- Focus Pharmacokinetics
- Sponsors Melinta Therapeutics
- 14 Aug 2018 Status changed from recruiting to completed.
- 28 May 2018 New trial record